These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

995 related items for PubMed ID: 19526730

  • 1. Is Alzheimer's disease a result of presynaptic failure? Synaptic dysfunctions induced by oligomeric beta-amyloid.
    Nimmrich V, Ebert U.
    Rev Neurosci; 2009; 20(1):1-12. PubMed ID: 19526730
    [Abstract] [Full Text] [Related]

  • 2. Synaptic changes in Alzheimer's disease and its models.
    Pozueta J, Lefort R, Shelanski ML.
    Neuroscience; 2013 Oct 22; 251():51-65. PubMed ID: 22687952
    [Abstract] [Full Text] [Related]

  • 3. Human Brain-Derived Aβ Oligomers Bind to Synapses and Disrupt Synaptic Activity in a Manner That Requires APP.
    Wang Z, Jackson RJ, Hong W, Taylor WM, Corbett GT, Moreno A, Liu W, Li S, Frosch MP, Slutsky I, Young-Pearse TL, Spires-Jones TL, Walsh DM.
    J Neurosci; 2017 Dec 06; 37(49):11947-11966. PubMed ID: 29101243
    [Abstract] [Full Text] [Related]

  • 4. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T.
    Brain Nerve; 2010 Jul 06; 62(7):691-9. PubMed ID: 20675873
    [Abstract] [Full Text] [Related]

  • 5. Drebrin in Alzheimer's Disease.
    Ishizuka Y, Hanamura K.
    Adv Exp Med Biol; 2017 Jul 06; 1006():203-223. PubMed ID: 28865022
    [Abstract] [Full Text] [Related]

  • 6. Alzheimer's disease-associated neurotoxic mechanisms and neuroprotective strategies.
    Pereira C, Agostinho P, Moreira PI, Cardoso SM, Oliveira CR.
    Curr Drug Targets CNS Neurol Disord; 2005 Aug 06; 4(4):383-403. PubMed ID: 16101556
    [Abstract] [Full Text] [Related]

  • 7. Soluble amyloid beta peptide concentration as a predictor of synaptic change in Alzheimer's disease.
    Lue LF, Kuo YM, Roher AE, Brachova L, Shen Y, Sue L, Beach T, Kurth JH, Rydel RE, Rogers J.
    Am J Pathol; 1999 Sep 06; 155(3):853-62. PubMed ID: 10487842
    [Abstract] [Full Text] [Related]

  • 8. Non-Fibrillar Oligomeric Amyloid-β within Synapses.
    Pickett EK, Koffie RM, Wegmann S, Henstridge CM, Herrmann AG, Colom-Cadena M, Lleo A, Kay KR, Vaught M, Soberman R, Walsh DM, Hyman BT, Spires-Jones TL.
    J Alzheimers Dis; 2016 May 30; 53(3):787-800. PubMed ID: 27258414
    [Abstract] [Full Text] [Related]

  • 9. Alzheimer's disease.
    De-Paula VJ, Radanovic M, Diniz BS, Forlenza OV.
    Subcell Biochem; 2012 May 30; 65():329-52. PubMed ID: 23225010
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Amyloid β oligomers suppress excitatory transmitter release via presynaptic depletion of phosphatidylinositol-4,5-bisphosphate.
    He Y, Wei M, Wu Y, Qin H, Li W, Ma X, Cheng J, Ren J, Shen Y, Chen Z, Sun B, Huang FD, Shen Y, Zhou YD.
    Nat Commun; 2019 Mar 13; 10(1):1193. PubMed ID: 30867420
    [Abstract] [Full Text] [Related]

  • 12. Neuromodulatory Action of Picomolar Extracellular Aβ42 Oligomers on Presynaptic and Postsynaptic Mechanisms Underlying Synaptic Function and Memory.
    Gulisano W, Melone M, Ripoli C, Tropea MR, Li Puma DD, Giunta S, Cocco S, Marcotulli D, Origlia N, Palmeri A, Arancio O, Conti F, Grassi C, Puzzo D.
    J Neurosci; 2019 Jul 24; 39(30):5986-6000. PubMed ID: 31127002
    [Abstract] [Full Text] [Related]

  • 13. Synaptic Plasticity, Dementia and Alzheimer Disease.
    Skaper SD, Facci L, Zusso M, Giusti P.
    CNS Neurol Disord Drug Targets; 2017 Jul 24; 16(3):220-233. PubMed ID: 28088900
    [Abstract] [Full Text] [Related]

  • 14. RAPGEF2 mediates oligomeric Aβ-induced synaptic loss and cognitive dysfunction in the 3xTg-AD mouse model of Alzheimer's disease.
    Jang YN, Jang H, Kim GH, Noh JE, Chang KA, Lee KJ.
    Neuropathol Appl Neurobiol; 2021 Aug 24; 47(5):625-639. PubMed ID: 33345400
    [Abstract] [Full Text] [Related]

  • 15. The synaptic protein neuroligin-1 interacts with the amyloid β-peptide. Is there a role in Alzheimer's disease?
    Dinamarca MC, Weinstein D, Monasterio O, Inestrosa NC.
    Biochemistry; 2011 Sep 27; 50(38):8127-37. PubMed ID: 21838267
    [Abstract] [Full Text] [Related]

  • 16. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK, Jara C, Park-Kang HS, Polanco CM, Tapia D, Alarcón F, de la Peña A, Llanquinao J, Vargas-Mardones G, Indo JA, Inestrosa NC, Tapia-Rojas C.
    J Alzheimers Dis; 2021 Sep 27; 84(4):1391-1414. PubMed ID: 34719499
    [Abstract] [Full Text] [Related]

  • 17. Co-occurrence of Alzheimer's disease ß-amyloid and τ pathologies at synapses.
    Takahashi RH, Capetillo-Zarate E, Lin MT, Milner TA, Gouras GK.
    Neurobiol Aging; 2010 Jul 27; 31(7):1145-52. PubMed ID: 18771816
    [Abstract] [Full Text] [Related]

  • 18. Soluble oligomeric amyloid-β induces calcium dyshomeostasis that precedes synapse loss in the living mouse brain.
    Arbel-Ornath M, Hudry E, Boivin JR, Hashimoto T, Takeda S, Kuchibhotla KV, Hou S, Lattarulo CR, Belcher AM, Shakerdge N, Trujillo PB, Muzikansky A, Betensky RA, Hyman BT, Bacskai BJ.
    Mol Neurodegener; 2017 Mar 21; 12(1):27. PubMed ID: 28327181
    [Abstract] [Full Text] [Related]

  • 19. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
    Decker H, Jürgensen S, Adrover MF, Brito-Moreira J, Bomfim TR, Klein WL, Epstein AL, De Felice FG, Jerusalinsky D, Ferreira ST.
    J Neurochem; 2010 Dec 21; 115(6):1520-9. PubMed ID: 20950339
    [Abstract] [Full Text] [Related]

  • 20. Neuroprotective Effects of Ferruginol, Jatrophone, and Junicedric Acid Against Amyloid-β Injury in Hippocampal Neurons.
    Zolezzi JM, Lindsay CB, Serrano FG, Ureta RC, Theoduloz C, Schmeda-Hirschmann G, Inestrosa NC.
    J Alzheimers Dis; 2018 Dec 21; 63(2):705-723. PubMed ID: 29660932
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 50.